TRCT
CBST

Tower Research Capital (TRC)’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Tower Research Capital (TRC)’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-544
Closed -$55K – 5513
2014
Q4 		$55K Buy
544
+198
+57% +$15.4K 0.01% 980
2014
Q3 		$23K Sell
346
-4,658
-93% -$306K ﹤0.01% 2209
2014
Q2 		$349K Buy
5,004
+816
+19% +$55.5K 0.04% 398
2014
Q1 		$307K Buy
4,188
+4,077
+3,673% +$304K 0.04% 296
2013
Q4 		$8K Sell
111
-89
-45% -$5.76K ﹤0.01% 3255
2013
Q3 		$13K Buy
+200
New +$12.1K ﹤0.01% 3051

Tower Research Capital (TRC)'s CBST Position: Q1 2015 in Review

Tower Research Capital (TRC) sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 544 shares — an estimated $55K sold.

Tower Research Capital (TRC) first reported a position in CBST in Q3 2013 and held it in 6 quarters. The position peaked at $349K in Q2 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Tower Research Capital (TRC) reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 544 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $55K.
  • Tower Research Capital (TRC) first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s CUBIST PHARMACEUTICALS INC position peaked at $349K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.